Literature DB >> 6298921

Monoclonal antibodies of hybridomas.

J G Sinkovics, G R Dreesman.   

Abstract

Among the most prominent biological advances of this century, the hybridoma technology stands out as providing the best tool for the analysis of complex antigens of pathogens and tumor cells. This technology will play a major role in the immunodiagnosis and treatment of infectious and malignant diseases. This review focuses on the most recent developments (1980-1981), with emphasis on human immunology.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6298921     DOI： 10.1093/clinids/5.1.9

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN： 0162-0886


  7 in total

1.  In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody.

Authors:  J J Starling; R S Maciak; N A Hinson; C L Nichols; S L Briggs; B C Laguzza
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Differences in antimicrobial susceptibilities of clinical isolates in Saudi Arabia and the United States.

Authors:  S M Qadri; S Ostrawski; S Johnson; D J Flournoy
Journal:  J Natl Med Assoc       Date:  1987-04       Impact factor: 1.798

3.  In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.

Authors:  H C Neu; N X Chin; G Saha; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

4.  Monoclonal antibodies and immobilized antibodies. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1985-06       Impact factor: 2.926

Review 5.  Molecular lesions in cancer.

Authors:  H Busch
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 6.  The application of monoclonal antibodies in the study of viruses.

Authors:  M J Carter; V ter Meulen
Journal:  Adv Virus Res       Date:  1984       Impact factor: 9.937

7.  Comments on cultured human sarcoma cells.

Authors:  Joseph G Sinkovics
Journal:  Sarcoma       Date:  2003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.